Chapter 534 Obstruction of the Urinary Tract
Table 534-1 TYPES AND CAUSES OF URINARY TRACT OBSTRUCTION
LOCATION | CAUSE |
---|---|
Infundibula | |
Renal pelvis | |
Ureteropelvic junction | |
Ureter | |
Bladder outlet and urethra |
Diagnosis
Imaging Studies
Renal Ultrasonography
The presence of a dilated urinary tract is the most common characteristic of obstruction. Hydronephrosis is a common ultrasonographic finding (Fig. 534-1). Dilation is not diagnostic of obstruction and can persist after surgical correction of an obstructive lesion. Dilation can result from vesicoureteral reflux, or it may be a manifestation of abnormal development of the urinary tract, even when there is no obstruction. Renal length, degree of caliectasis and parenchymal thickness, and presence or absence of ureteral dilation should be assessed. Ideally, the severity of hydronephrosis should be graded from 1 to 4 using the Society for Fetal Urology grading scale (Table 534-2). The clinician should ascertain that the contralateral kidney is normal, and the bladder should be imaged to see whether the bladder wall is thickened, the lower ureter is dilated, and bladder emptying is complete. In acute or intermittent obstruction, the dilation of the collecting system may be minimal and ultrasonography may be misleading.
Table 534-2 SOCIETY FOR FETAL UROLOGY GRADING SYSTEM FOR HYDRONEPHROSIS
RENAL IMAGE | ||
---|---|---|
GRADE OF HYDRONEPHROSIS | Central Renal Complex | Renal Parenchymal Thickness |
0 | Intact | Normal |
1 | Slight splitting | Normal |
2 | Evident splitting, complex confined within renal border | Normal |
3 | Wide splitting pelvis dilated outside renal border, calyces uniformly dilated | Normal |
4 | Further dilatation of pelvis and calyces (calyces may appear convex) | Thin |
After Maizels M, Mitchell B, Kass E, et al: Outcome of nonspecific hydronephrosis in the infant: a report from the registry of the Society for Fetal Urology, J Urol 152:2324–2327, 1994.
Radioisotope Studies
In a MAG-3 diuretic renogram, a small dose of technetium-labeled MAG-3 is injected intravenously (Figs. 534-2 and 534-3). During the first 2-3 min, renal parenchymal uptake is analyzed and compared, allowing computation of differential renal function. Subsequently, excretion is evaluated. After 20-30 min, furosemide 1 mg/kg is injected intravenously, and the rapidity and pattern of drainage from the kidneys to the bladder are analyzed. If no obstruction is present, half of the radionuclide should be cleared from the renal pelvis within 10-15 min, termed the half-time (t1/2). If there is significant upper tract obstruction, the t1/2 usually is >20 min. A t1/2 of 15-20 min is indeterminate. The images generated usually provide an accurate assessment of the site of obstruction. Numerous variables affect the outcome of the diuretic renogram. Newborn kidneys are functionally immature, and, in the first month of life, normal kidneys might not demonstrate normal drainage after diuretic administration. Dehydration prolongs parenchymal transit and can blunt the diuretic response. Giving an insufficient dose of furosemide can result in inadequate drainage. If vesicoureteral reflux is present, continuous bladder drainage is mandatory to prevent the radionuclide from refluxing from the bladder into the dilated upper tract, which would prolong the washout phase.